URS
MRTX

Utah Retirement Systems’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Utah Retirement Systems’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,700
Closed -$349K – 1007
2022
Q4 		$349K Hold
7,700
– – 0.01% 839
2022
Q3 		$538K Buy
7,700
+100
+1% +$7.4K 0.01% 806
2022
Q2 		$511K Hold
7,600
– – 0.01% 819
2022
Q1 		$625K Hold
7,600
– – 0.01% 823
2021
Q4 		$1.11M Buy
7,600
+500
+7% +$77.6K 0.01% 753
2021
Q3 		$1.26M Sell
7,100
-300
-4% -$48.3K 0.02% 729
2021
Q2 		$1.2M Buy
7,400
+1,500
+25% +$241K 0.02% 753
2021
Q1 		$1.01M Buy
+5,900
New +$1.17M 0.01% 777

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Utah Retirement Systems's MRTX Position: Q1 2023 in Review

Utah Retirement Systems sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2023, closing a stake of 7,700 shares — an estimated $349K sold.

Utah Retirement Systems first reported a position in MRTX in Q1 2021 and held it in 8 quarters. The position peaked at $1.26M in Q3 2021. 221 funds tracked by Wall St. Rank hold MRTX as of Q1 2023.

  • Utah Retirement Systems reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Utah Retirement Systems sold 7,700 Mirati Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $349K.
  • Utah Retirement Systems first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Utah Retirement Systems's Mirati Therapeutics, Inc. Common Stock position peaked at $1.26M in Q3 2021.
  • 221 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Utah Retirement Systems's 13F filing for Q1 2023, filed 16 May 2023.